Tag: <span>Gene Therapy</span>

Home / Gene Therapy
Post

Duchenne Muscular Dystrophy Gene Therapy Safe, Effective at 4 Years

Nancy A. Melville November 06, 2023 PHOENIX — Children with Duchenne muscular dystrophy (DMD) treated with the only gene therapy to date to be approved for treatment of disease in the United States show sustained maintenance of motor function after 4 years, compared with untreated patients who showed significant decline over the same time period, new research...

Researchers pursue three gene therapies for rare inherited disease
Post

Researchers pursue three gene therapies for rare inherited disease

by Catherine Caruso, Harvard Medical School Credit: Pixabay/CC0 Public DomainWhen neurobiologist David Corey showed up at a rare disease conference in 2017, he had no idea that he would enter a race against time to develop a treatment for it. The conference was for Usher syndrome type 1F. Patients with this condition have a gene mutation...

Researchers design gene therapy that can effectively target glioblastoma
Post

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women’s Hospital Glioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the body’s immune defenses against a cancer, have not been effective for GBM, in part because the tumor’s surrounding environment...

Gene therapy study identifies potential new treatment for liver cancer
Post

Gene therapy study identifies potential new treatment for liver cancer

by UC Davis Graphical Abstract. Credit: Molecular Therapy (2023). DOI: 10.1016/j.ymthe.2023.04.019 Gene therapy that induces the body to create microRNA-22 (miR-22), a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma, the most common form of liver cancer. The miR-22 treatment also reduced liver inflammation and produced better survival outcomes with no observable toxicity compared...

Post

Study shows promise of gene therapy for alcohol use disorder

OREGON HEALTH & SCIENCE UNIVERSITY A form of gene therapy currently used to treat Parkinson’s disease may dramatically reduce alcohol use among chronic heavy drinkers, researchers at Oregon Health & Science University and institutions across the country have found. The study in nonhuman primates showed that implanting a specific type of molecule that induces cell growth effectively...

Research sheds new light on gene therapy for blood disorders
Post

Research sheds new light on gene therapy for blood disorders

by University of Michigan Credit: National Institutes of Health Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy. The study is published in the journal Science. To cure blood disorders, patients must undergo high dose chemotherapy...

Gene therapy hope for children with kidney disease
Post

Gene therapy hope for children with kidney disease

by University of Bristol Image [left to right]: Professor Moin Saleem, Dr Wen Ding [Academic Clinical Lecturer in Paediatric Renal Medicine] and Professor Gavin Welch [Professor of Renal Cell Biology] from the University of Bristol’s Medical School Credit: Kidney Research UK Researchers at the University of Bristol have made a remarkable step forward in finding a potential cure for...

Gene therapy treats chronic pain by dialing down sodium
Post

Gene therapy treats chronic pain by dialing down sodium

NEW YORK UNIVERSITY IMAGE: AN ARTISTIC REPRESENTATION OF THE INTERACTION BETWEEN THE NAV1.7 SODIUM ION CHANNEL AND COLLAPSIN RESPONSE MEDIATOR PROTEIN 2 (CRMP2). THE RESEARCHERS IDENTIFIED A UNIQUE REGULATORY SEQUENCE IN NAV1.7 THAT IS REQUIRED FOR NAV1.7 FUNCTION. THEY FOUND THAT THIS PEPTIDE DISRUPTED THE INTERACTION WITH CRMP2 AND REDUCED EXCITABILITY IN SENSORY NEURONS. THE...

Post

Gene Therapy Promising for Reversal of Hereditary Vision Loss

Liam Davenport July 13, 2023 An unapproved gene therapy for Leber hereditary optic neuropathy (LHON) led to a marked improvement in the eyesight of patients with a severe, progressive form of the disease who received the therapy as part of an early access program. Results of a study of more than 60 patients who received lenadogene nolparvovec...